# US 2025/0026810 A1 · Production of heteromultimeric proteins using mammalian cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0026810 A1
- Document ID: US20250026810A1
- Status: Published application
- Kind: A1
- Application number: 18/674,708
- Filed: 2024-05-24
- Published: 2025-01-23
- Earliest claimed: 2014-05-06
- Assignees: Genentech, Inc.
- Applicants: Genentech, Inc.
- Inventors: Justin SCHEER; Whitney SHATZ; Domingos NG
- Web page: https://patentgrep.com/patent/US20250026810A1

## CPC

- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 16/468: {Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies}
- C07K 2317/14: Specific host cells or culture conditions, e.g. components, pH or temperature
- C07K 2317/31: multispecific
- C07K 2317/52: Constant or Fc region; Isotype
- C07K 2317/526: CH3 domain
- C07K 2317/53: Hinge
- C12N 15/79: Vectors or expression systems specially adapted for eukaryotic hosts
- C12N 15/907: {in mammalian cells}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Described herein are methods for the efficient production of antibodies and other multimeric protein complexes (collectively referred to herein as heteromultimeric proteins) capable of specifically binding to more than one target. The targets may be, for example, different epitopes located on a single molecule or located on different molecules.

## Claims

### Claim at position 1

1-64. (canceled)

### Claim 65

A method of preparing a heteromultimeric protein comprising i) a first hinge-containing polypeptide comprising a first heterodimerization domain, wherein the first hinge-containing polypeptide is associated with a first light chain, and ii) a second hinge-containing polypeptide comprising a second heterodimerization domain, wherein the second hinge-containing polypeptide is associated with a second light chain, wherein the second heterodimerization domain interacts with the first heterodimerization domain at an interface, and wherein the first and second hinge-containing polypeptides are linked by at least one interchain disulfide bond, the method comprising the steps of:
(a) adding a reducing agent to a combined culture comprising a first host cell and a second host cell, wherein the first host cell is capable of expressing the first hinge-containing polypeptide and the first light chain, wherein the second host cell is capable of expressing the second hinge-containing polypeptide and the second light chain, and wherein the first host cell and the second host cell are each a mammalian cell; and
(b) harvesting a combined culture medium from the combined culture after adding the reducing agent, wherein the harvesting comprises removing the first host cell and the second host cell from the combined culture medium without disrupting cell membranes of the first host cell and the second host cell, and wherein the combined culture medium comprises the heteromultimeric protein.

### Claim 66 (depends on 65)

The method of claim 65, wherein the harvesting of the combined culture medium is about 4 hours to about 24 hours after adding the reducing agent to the combined culture.

### Claim 67 (depends on 65)

The method of claim 65, further comprising culturing the first host cell and the second host cell before step (a).

### Claim 68 (depends on 67)

The method of claim 67, wherein the first host cell and the second host cell are cultured separately.

### Claim 69 (depends on 67)

The method of claim 67, wherein the first host cell and the second host cell are cultured together.

### Claim 70 (depends on 65)

The method of claim 65, wherein the reducing agent is glutathione (GSH).

### Claim 71 (depends on 70)

The method of claim 70, wherein the GSH is added at a concentration of about 5 mM to no more than about 20 mM.

### Claim 72 (depends on 65)

The method of claim 65, wherein the first hinge-containing polypeptide and the second hinge-containing polypeptide each comprises an antibody heavy chain.

### Claim 73 (depends on 72)

The method of claim 72, wherein:
(i) the first heterodimerization domain comprises a knob modification and the second heterodimerization domain comprises a hole modification; or
(ii) the first heterodimerization domain comprises a hole modification and the second heterodimerization domain comprises a knob modification.

### Claim 74 (depends on 73)

The method of claim 73, wherein the knob modification comprises a T366W substitution according to EU numbering, and the hole modification comprises two or more substitutions selected from the group consisting of T366S, L368A, and Y407V according to EU numbering.

### Claim 75 (depends on 65)

The method of claim 65, wherein the mammalian cell is a Chinese hamster ovary (CHO) cell or a stable cell line.

### Claim 76 (depends on 65)

The method of claim 65, further comprising isolating the heteromultimeric protein from the combined culture medium after step (b).

### Claim 77 (depends on 67)

The method of claim 67, further comprising introducing one or more nucleic acids encoding the first hinge-containing polypeptide and the first light chain into the first host cell before culturing the first host cell, and introducing one or more nucleic acids encoding the second hinge-containing polypeptide and the second light chain into the second host cell before culturing the second host cell.

### Claim 78 (depends on 68)

The method of claim 68, further comprising combining the separately cultured first host cell and the second host cell to obtain the combined culture.

### Claim 79 (depends on 65)

The method of claim 65, wherein the heteromultimeric protein is a bispecific antibody.

### Claim 80

A method of preparing a heteromultimeric protein comprising i) a first hinge-containing polypeptide comprising a first heterodimerization domain, wherein the first hinge-containing polypeptide is associated with a first light chain, and ii) a second hinge-containing polypeptide comprising a second heterodimerization domain, wherein the second hinge-containing polypeptide is associated with a second light chain, wherein the second heterodimerization domain interacts with the first heterodimerization domain at an interface, and wherein the first and second hinge-containing polypeptides are linked by at least one interchain disulfide bond, the method comprising the steps of:
(a) adding a reducing agent to a combined culture medium, wherein the combined culture medium comprises (1) the first hinge-containing polypeptide and the first light chain expressed from a first mammalian host cell, and (2) the second hinge-containing polypeptide and the second light chain expressed from a second mammalian host cell, and wherein the combined culture medium is obtained without disrupting cell membranes of the first mammalian host cell and the second mammalian host cell; and
(b) incubating the combined culture medium with the reducing agent for about 4 hours to about 7 days, wherein the combined culture medium comprises the heteromultimeric protein.

### Claim 81

A method of reducing homodimers from a combined culture medium, wherein the combined culture medium comprises (i) a first homodimer comprising two first hinge-containing polypeptides and two first light chains expressed from a first mammalian host cell, and (ii) a second homodimer comprising two second hinge-containing polypeptides and two second light chains expressed from a second mammalian host cell;
wherein the first hinge-containing polypeptide comprises a first heterodimerization domain, wherein the second hinge-containing polypeptide comprises a second heterodimerization domain, wherein the second heterodimerization domain is capable of interacting with the first heterodimerization domain at an interface, wherein the first and second hinge-containing polypeptides are capable of being linked by at least one interchain disulfide bond; and
wherein the method comprises the steps of:
(a) adding a reducing agent to the combined culture medium; and
(b) incubating the combined culture medium with the reducing agent to allow formation of a heteromultimeric protein comprising the first hinge-containing polypeptide, the first light chain, the second hinge-containing polypeptide, and the second light chain, thereby reducing the first homodimer and the second homodimer from the combined culture medium.

### Claim 82

A method of preparing a heteromultimeric protein comprising i) a first hinge-containing polypeptide comprising a first heterodimerization domain, wherein the first hinge-containing polypeptide is associated with a first light chain, and ii) a second hinge-containing polypeptide comprising a second heterodimerization domain, wherein the second hinge-containing polypeptide is associated with a second light chain, wherein the second heterodimerization domain interacts with the first heterodimerization domain at an interface, and wherein the first and second hinge-containing polypeptides are linked by at least one interchain disulfide bond, the method comprising the steps of:
(a) adding a first reducing agent to a first culture medium, wherein the first culture medium comprises the first hinge-containing polypeptide and the first light chain expressed by a first mammalian host cell, and wherein the first culture medium does not comprise the first mammalian host cell;
(b) adding a second reducing agent to a second culture medium, wherein the second culture medium comprises the second hinge-containing polypeptide and the second light chain expressed by a second mammalian host cell, and wherein the second culture medium does not comprise the second mammalian host cell; and
(c) obtaining a combined culture medium by combining the first culture medium added with the first reducing agent and the second culture medium added with the second reducing agent, wherein the combined culture medium comprises the heteromultimeric protein.

### Claim 83

A method of preparing a heteromultimeric protein comprising i) a first hinge-containing polypeptide comprising a first heterodimerization domain, wherein the first hinge-containing polypeptide is associated with a first light chain, and ii) a second hinge-containing polypeptide comprising a second heterodimerization domain, wherein the second hinge-containing polypeptide is associated with a second light chain, wherein the second heterodimerization domain interacts with the first heterodimerization domain at an interface, and wherein the first and second hinge-containing polypeptides are linked by at least one interchain disulfide bond, the method comprising the steps of:
(a) adding a first reducing agent to a first culture comprising a first mammalian host cell, wherein the first mammalian host cell is capable of expressing the first hinge-containing polypeptide and the first light chain;
(b) adding a second reducing agent to a second culture comprising a second mammalian host cell, wherein the second mammalian host cell is capable of expressing the second hinge-containing polypeptide and the second light chain;
(c) harvesting a first culture medium from the first culture added with the first reducing agent without disrupting the cell membrane of the first mammalian host cell;
(d) harvesting a second culture medium from the second culture added with the second reducing agent without disrupting the cell membrane of the second mammalian host cell; and
(e) obtaining a combined culture medium by combining the first culture medium from step (c) and the second culture medium from step (d), wherein the combined culture medium comprises the heteromultimeric protein.

### Claim 84 (depends on 65)

A heteromultimeric protein produced by the method of claim 65.
